2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 1.279.552 | 1.126.992 | 1.291.100 | 1.161.164 | 885.762 | 1.150.666 | 1.226.201 | 1.508.926 | 2.038.196 | 1.612.866 |
Total Income - EUR | 1.209.568 | 1.150.780 | 1.302.795 | 1.223.617 | 1.132.231 | 1.155.872 | 1.365.657 | 1.431.122 | 2.019.969 | 1.883.236 |
Total Expenses - EUR | 1.158.600 | 1.135.461 | 1.266.764 | 1.111.894 | 1.072.907 | 1.096.277 | 1.298.386 | 1.360.904 | 1.852.638 | 1.719.999 |
Gross Profit/Loss - EUR | 50.968 | 15.320 | 36.031 | 111.723 | 59.324 | 59.594 | 67.270 | 70.219 | 167.331 | 163.236 |
Net Profit/Loss - EUR | 41.677 | 10.919 | 30.376 | 62.559 | 50.780 | 50.191 | 57.454 | 61.421 | 147.021 | 141.390 |
Employees | 11 | 11 | 13 | 15 | 15 | 12 | 12 | 13 | 13 | 15 |
Check the financial reports for the company - Pharmaplant Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 522.294 | 550.097 | 424.766 | 476.507 | 564.658 | 1.427.315 | 1.480.623 | 1.530.909 | 1.409.595 | 1.501.585 |
Current Assets | 575.356 | 721.236 | 818.288 | 587.102 | 927.076 | 1.049.673 | 755.256 | 880.927 | 824.742 | 1.069.401 |
Inventories | 408.490 | 347.978 | 403.720 | 373.550 | 619.628 | 551.336 | 623.541 | 537.913 | 729.429 | 583.196 |
Receivables | 117.759 | 364.714 | 427.058 | 189.293 | 299.423 | 371.134 | 66.371 | 291.264 | 24.435 | 340.857 |
Cash | 49.107 | 8.544 | -12.491 | 24.259 | 8.025 | 127.203 | 65.344 | 51.750 | 70.878 | 145.348 |
Shareholders Funds | 204.275 | 205.980 | 203.879 | 262.142 | 308.111 | 922.965 | 954.652 | 994.903 | 1.134.871 | 1.272.820 |
Social Capital | 127.193 | 128.254 | 126.946 | 124.798 | 122.508 | 120.135 | 117.858 | 115.244 | 115.602 | 115.251 |
Debts | 866.377 | 1.052.403 | 1.075.236 | 803.176 | 1.184.512 | 1.554.734 | 1.281.432 | 1.429.646 | 1.100.087 | 1.299.208 |
Income in Advance | 35.417 | 13.164 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "111 - 111" | |||||||||
CAEN Financial Year |
111
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Pharmaplant Srl